Literature DB >> 22435680

Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.

Piero Anversa1, Mark A Perrella, Stella Kourembanas, Augustine M K Choi, Joseph Loscalzo.   

Abstract

BACKGROUND: Chronic lung diseases contribute significantly to the morbidity and mortality of the population. There are few effective treatments for many chronic lung diseases, and even fewer therapies that can arrest or reverse the progress of the disease.
DESIGN: In this review, we present the current state of regenerative therapies for the treatment of chronic lung diseases. We focus on endothelial progenitor cells, mesenchymal stem cells, and endogenous lung stem/progenitor cells; summarize the work to date in models of lung diseases for each of these therapies; and consider their potential benefits and risks as viable therapies for patients with lung diseases.
CONCLUSIONS: Cell-based regenerative therapies for lung diseases offer great promise, with preclinical studies suggesting that the next decade should provide the evidence necessary for their ultimate application to our therapeutic armamentarium.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Year:  2012        PMID: 22435680      PMCID: PMC3513384          DOI: 10.1111/j.1365-2362.2012.02667.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  134 in total

1.  A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse.

Authors:  J E Dennis; A Merriam; A Awadallah; J U Yoo; B Johnstone; A I Caplan
Journal:  J Bone Miner Res       Date:  1999-05       Impact factor: 6.741

2.  Molecular phenotype of airway side population cells.

Authors:  Adam Giangreco; Hongmei Shen; Susan D Reynolds; Barry R Stripp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-08       Impact factor: 5.464

3.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 4.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 5.  Hierarchical organization of lung progenitor cells: is there an adult lung tissue stem cell?

Authors:  Barry R Stripp
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

6.  Tumors originating from induced pluripotent stem cells and methods for their prevention.

Authors:  Dirk Duinsbergen; Daniela Salvatori; Malin Eriksson; Harald Mikkers
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

7.  Tissue-specific adult stem cells in the human lung.

Authors:  Piero Anversa; Jan Kajstura; Annarosa Leri; Joseph Loscalzo
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

8.  Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection.

Authors:  Pooja A Kumar; Yuanyu Hu; Yusuke Yamamoto; Neo Boon Hoe; Tay Seok Wei; Dakai Mu; Yan Sun; Lim Siew Joo; Rania Dagher; Elisabeth M Zielonka; De Yun Wang; Bing Lim; Vincent T Chow; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

9.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice.

Authors:  S F Yet; M A Perrella; M D Layne; C M Hsieh; K Maemura; L Kobzik; P Wiesel; H Christou; S Kourembanas; M E Lee
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  12 in total

1.  Comparative study of immune regulatory properties of stem cells derived from different tissues.

Authors:  Mariano Di Trapani; Giulio Bassi; Mario Ricciardi; Emanuela Fontana; Francesco Bifari; Luciano Pacelli; Luca Giacomello; Michela Pozzobon; Francois Féron; Paolo De Coppi; Piero Anversa; Guido Fumagalli; Ilaria Decimo; Cedric Menard; Karin Tarte; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2013-08-09       Impact factor: 3.272

Review 2.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

Review 3.  Aging and Lung Disease. Clinical Impact and Cellular and Molecular Pathways.

Authors:  Mauricio Rojas; Ana L Mora; Maria Kapetanaki; Nathaniel Weathington; Mark Gladwin; Oliver Eickelberg
Journal:  Ann Am Thorac Soc       Date:  2015-12

Review 4.  Stem and progenitor cell therapy for pulmonary arterial hypertension: effects on the right ventricle (2013 Grover Conference Series).

Authors:  Arnoud van der Laarse; Christa M Cobbaert; Soban Umar
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

5.  Ethics and policy issues for stem cell research and pulmonary medicine.

Authors:  Justin Lowenthal; Jeremy Sugarman
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 6.  Experimental basis and new insights for cell therapy in Chronic Obstructive Pulmonary Disease.

Authors:  Carolina Arruda de Faria; Rodrigo de las Heras Kozma; Talita Stessuk; João Tadeu Ribeiro-Paes
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

7.  Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis.

Authors:  Anandharajan Rathinasabapathy; Erin Bruce; Andrew Espejo; Alana Horowitz; Dhivya R Sudhan; Anand Nair; Dominic Guzzo; Joseph Francis; Mohan K Raizada; Vinayak Shenoy; Michael J Katovich
Journal:  Br J Pharmacol       Date:  2016-08-26       Impact factor: 8.739

Review 8.  Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?

Authors:  Nurdan Kokturk; Fatma Yıldırım; Pınar Yıldız Gülhan; Yeon Mok Oh
Journal:  Am J Stem Cells       Date:  2018-08-01

Review 9.  MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension.

Authors:  Zhaowei Zhu; Zhenfei Fang; Xinqun Hu; Shenghua Zhou
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Sep

Review 10.  Cell-based therapy in lung regenerative medicine.

Authors:  Jibing Yang; Zhenquan Jia
Journal:  Regen Med Res       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.